Plain-English translation of NCT07290803 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This is a registry study—a long-term observation of how systemic treatments work for atopic dermatitis (a chronic skin condition causing itching, redness, and inflammation) in real life. Instead of testing a single new drug, researchers will follow patients like you who are starting or switching to any systemic treatment for atopic dermatitis—such as biologics, JAK inhibitors, cyclosporine, or other medications—to understand how well these treatments work, what side effects occur, and how different patient factors affect outcomes.
Many people with atopic dermatitis still struggle to find effective treatments, and doctors need better information about how these medications perform in everyday practice across different patients and countries. This study aims to fill that gap by collecting real-world data that helps doctors understand which treatments work best for whom.
You likely qualify if…
You likely don't qualify if…
You will continue taking the treatment your doctor prescribes as part of your regular care—this is not an experimental medication trial. Over 5 years, you will share information about your medical history, skin symptoms, treatment responses, and any side effects through periodic visits and check-ins with the research team. The study will track you across 10 countries to understand how different factors (like age, skin tone, triggers, and other health conditions) influence your treatment journey.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States